A rating of 83 puts Infinity Pharmaceuticals Inc. (INFI) near the top of the Biotechnology industry according to InvestorsObserver. Infinity Pharmaceuticals Inc.'s score of 83 means it scores higher than 83% of stocks in the industry. Infinity Pharmaceuticals Inc. also received an overall rating of 51, putting it above 51% of all stocks. Biotechnology is ranked 103 out of the 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Infinity Pharmaceuticals Inc. Stock Today?
Infinity Pharmaceuticals Inc. (INFI) stock is down -5.09% while the S&P 500 has gained 0.68% as of 2:37 PM on Friday, Jul 2. INFI is down -$0.15 from the previous closing price of $3.00 on volume of 1,497,109 shares. Over the past year the S&P 500 has risen 38.95% while INFI has gained 220.22%. INFI lost -$0.64 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Infinity Pharmaceuticals Inc. (INFI) Stock.
